Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2021-01-27 2021-01-12
Drug Identification Number 00585092 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name DEPO-PROVERA DEPO-PROVERA
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG 150MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 1ML 5 x 1ML
ATC code G03AC G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-07-01
Actual start date 2021-01-12
Estimated end date 2022-06-01 2022-06-01
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Company comments Available inventory is currently on preventative allocation. Limited inventory available and on preventative allocation.
Health Canada comments